原发性硬化性胆管炎患者的胆管癌监测建议。

IF 2.9 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Daniel Saca MD, Steven L. Flamm MD
{"title":"原发性硬化性胆管炎患者的胆管癌监测建议。","authors":"Daniel Saca MD, Steven L. Flamm MD","doi":"10.1016/j.cld.2023.07.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10489,"journal":{"name":"Clinics in liver disease","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis\",\"authors\":\"Daniel Saca MD, Steven L. Flamm MD\",\"doi\":\"10.1016/j.cld.2023.07.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10489,\"journal\":{\"name\":\"Clinics in liver disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics in liver disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1089326123000909\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics in liver disease","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1089326123000909","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

胆管癌(CCA)是原发性硬化性胆管炎(PSC)的致命并发症。当症状出现并诊断为CCA时,通常处于晚期。中位生存期不到12个月。早期识别CCA可改善结果。尽管诊断测试具有极好的特异性,但它们的灵敏度低。没有广泛同意的监测策略,但大多数协会建议PSC患者每6至12个月测量一次血清碳水化合物抗原19-9和MRCP。人们期待着对导致CCA的遗传因素的理解取得进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinics in liver disease
Clinics in liver disease GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.30
自引率
0.00%
发文量
79
审稿时长
>12 weeks
期刊介绍: A perfect source to consult for those in the fields of gastroenterology and hepatology, Clinics in Liver Disease provides answers to clinical questions, information on the latest diagnostic methods and treatments, and numerous clinical images. Published quarterly—in February, May, August, and November—each issue offers in-depth reviews that focus on the liver and biliary system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信